Development and Characterization of Sorafenib-Loaded PLGA Nanoparticles for the Systemic Treatment of Liver Fibrosis
碩士 === 國立清華大學 === 生物醫學工程研究所 === 103 === Sorafenib, a tyrosine kinase inhibitor, has been shown as a potential antifibrotic agent. However, a narrow therapeutic window limits its clinical use and therapeutic efficacy of sorafenib. Herein we have developed and designed a drug delivery system - nanop...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2015
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/y35y8x |